Dwight Stapleton
Overview
Explore the profile of Dwight Stapleton including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
184
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mishra A, Singh M, Acker W, Kamboj S, Sporn D, Stapleton D, et al.
J Cardiovasc Pharmacol
. 2019 Jul;
74(2):82-90.
PMID: 31306367
Aim: The objective of this article is to review the contemporary literature on the use of antithrombotic therapy in patients with atrial fibrillation (AF) and coronary artery disease after undergoing...
2.
Urooj F, Kulkarni A, Stapleton D, Kaluski E
Clin Cardiol
. 2016 Oct;
39(12):739-746.
PMID: 27716952
The choice of an oral anticoagulant (OAC) for patients with nonvalvular atrial fibrillation (NVAF) is a major and complex clinical decision taking into account the individual risk-benefit ratio and bearing...
3.
Ali F, Rehman H, Babayan Z, Stapleton D, Joshi D
Postgrad Med
. 2015 Jan;
127(3):308-22.
PMID: 25560302
Purpose: With the rising consumption of so-called energy drinks over the last few years, there has been a growing body of literature describing significant adverse health events after the ingestion...
4.
Harjai K, Samy S, Pennypacker B, Onofre B, Stanfield P, Yaeger L, et al.
J Interv Cardiol
. 2012 Aug;
25(6):557-64.
PMID: 22861054
Hybrid coronary revascularization, which involves minimally invasive direct coronary artery bypass surgery using the left internal mammary artery to left anterior descending and percutaneous coronary intervention using drug-eluting stents for...
5.
Singla A, Jagasia D, Garg M, Lowry P, Stapleton D
Platelets
. 2012 Jun;
23(6):463-6.
PMID: 22686448
Essential thrombocythemia (ET) is a myeloproliferative disorder characterized by hemorrhagic and thrombotic complications. We describe a rare case of ST-segment elevation myocardial infarction (STEMI) in a patient with previously undiagnosed...
6.
Prasad H, Ryan D, Celzo M, Stapleton D
Postgrad Med
. 2012 Feb;
124(1):21-30.
PMID: 22314111
The collection of impaired glucose metabolism, central obesity, elevated blood pressure, and dyslipidemia is identified as metabolic syndrome (MetS). It is estimated that approximately 25% of the world's population has...
7.
Harjai K, Orshaw P, Shenoy C, Acharji S, Sporn D, Aboufares A, et al.
J Interv Cardiol
. 2008 Aug;
21(4):315-24.
PMID: 18754967
Objectives: We assessed outcomes of patients undergoing drug-eluting stent (DES) vs. bare metal stent (BMS) implantation for complex lesions excluded from pivotal clinical trials of DES. Background: Although DES improve...
8.
Harjai K, Raizada A, Shenoy C, Sattur S, Orshaw P, Yaeger K, et al.
Am J Cardiol
. 2008 Mar;
101(6):812-9.
PMID: 18328846
Contrast-induced nephropathy (CIN) after percutaneous coronary intervention (PCI) has multiple definitions. We attempted to identify the optimal definition of CIN. In 985 patients undergoing PCI (derivation group), we assessed the...
9.
Ali A, Cox D, Dib N, Brodie B, Berman D, Gupta N, et al.
J Am Coll Cardiol
. 2006 Jul;
48(2):244-52.
PMID: 16843170
Objectives: The goal of this work was to determine whether rheolytic thrombectomy (RT) as an adjunct to primary percutaneous coronary intervention (PCI) reduces infarction size and improves myocardial perfusion during...